INCOG BioPharma Services Plans Fishers, Indiana, Manufacturing Operations
12/24/2025
The $200 million investment at the company's existing facility will increase its injectable drug product manufacturing capacity, enabling the production of up to 480 million units per year.
"The continued demand from our global biopharma partners and our team's ability to deliver create the opportunity for this next level of investment and expansion," said Cory Lewis, CEO of INCOG BioPharma. "Committing another $200 million and employing nearly 1,000 team members by 2030 underscores our dedication to continue providing world-class, flexible manufacturing capacity while creating generational opportunities for the talented workforce here in central Indiana. This is a vote of confidence in our team, our quality, and our future."
The project is being supported by incentives offered by the State of Indiana.
"INCOG BioPharma's expansion is yet another example of Indiana leading in life sciences and advanced manufacturing. This major investment further positions us as one of the nation's top hubs for innovative drug development and will bring hundreds of new, high-paying jobs to our state. I'm proud to see companies like INCOG choose Indiana as the place to grow," noted Indiana Governor Mike Braun.
INCOG BioPharma is a fill/finish CDMO providing end-to-end solutions for clinical through commercial phase sterile injectable drug products for the biopharmaceutical market.
Project Announcements
Interstate Group Expands Giles County, Virginia, Production Operations
03/11/2026
Shinhwa Auto USA Expands Auburn, Alabama, Operations
03/11/2026
General Atomics Expands Shannon, Mississippi, Production Operations
03/11/2026
Starbucks Plans Davidson County, Tennessee, Corporate Operations
03/08/2026
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
AeroVironment Expands Albuquerque, New Mexico, Manufacturing Operations
03/08/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025